Conquest Research Revenue and Competitors

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • Conquest Research's estimated annual revenue is currently $5.2M per year.(i)
  • Conquest Research's estimated revenue per employee is $91,800

Employee Data

  • Conquest Research has 57 Employees.(i)
  • Conquest Research grew their employee count by 39% last year.

Conquest Research's People

NameTitleEmail/Phone
1
CEO & FounderReveal Email/Phone
2
Chief Medical OfficerReveal Email/Phone
3
Site DirectorReveal Email/Phone
4
Director Business OperationsReveal Email/Phone
5
Director Physician Engagement & Site DevelopmentReveal Email/Phone
6
Front Office CoordinatorReveal Email/Phone
7
Patient Recruitment SpecialistReveal Email/Phone
8
Clinical Research CoordinatorReveal Email/Phone
9
Principal InvestigatorReveal Email/Phone
10
Patient Recruitment Specialist IReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.8M13-7%N/AN/A
#2
$0.4M80%N/AN/A
#3
$16.3M1451%N/AN/A
#4
$5.2M574%N/AN/A
#5
$6.6M724%N/AN/A
#6
$9.1M896%N/AN/A
#7
$3.5M4310%N/AN/A
#8
$20.3M1811%N/AN/A
#9
$20.6M1844%N/AN/A
#10
$6.2M67-1%N/AN/A
Add Company

What Is Conquest Research?

Conquest Research was formed to offer the most efficient clinical research services to partners and pharmaceutical companies worldwide. With a leader who’s extremely passionate about advancing the clinical trial process through technology, our mission is to deliver high quality clinical research in a cost-effective and timely manner. Conquest Research offers services not only directly to pharmaceutical companies, but also to physician practices interested in conducting clinical trials to offer new and innovative treatment options to their patients.

keywords:N/A

N/A

Total Funding

57

Number of Employees

$5.2M

Revenue (est)

39%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$11.8M585%N/A
#2
$14.1M585%N/A
#3
$6.7M629%N/A
#4
$3.5M645%N/A
#5
$10.4M648%N/A